Introduction to Special Issue
Science commemorates the 40th anniversary of the U.S. National Cancer Act, which provided a massive stimulus for cancer research.
Researchers hope to figure out how tumors escape; they aim to turn months of survival into years.
More patients and the rising costs of new cancer treatments spark debate over how much is too much—and who should decide.
Cancer and other chronic diseases have received little attention from global health advocates. That's beginning to change.
Felicia Knaul, a health economist at Harvard Medical School in Boston, is one half of a Mexican-Canadian power couple that
aims to end the neglect of cancer as a disease of the poor—and will succeed, if anyone can, say colleagues.